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DECARBOXYLATION STUDIES OF GLUTAMATE,
GLUTAMINE, AND ASPARTATE FROM BRAIN
LABELLED WITH [l-14C]ACETATE, L-[U-14 C]ASPARTATE, AND L-[U-14C]GLUTAMATE
W. J. NICKLAS1 and D. D. CLARKE
Chemistry J:?epartment, Fordham University, Bronx, N.Y.

and

S. BERL2
Department of Neurology, College of Physicians and Surgeons, Columbia
University, New York, N.Y.
(Received 20 June 1968)

Abstract-Studies in vivo and in vitro of the distribution of label in C-1 of glutamate and
glutamine and C-4 of aspartate in the free amino acids of brain were carried out. [1-14C]Acetate was used both in vivo and in vitro and L-[U-14C]aspartate and L-[U-14C]glutamate
were used in vitro.
(1) The results obtained with labelled acetate and aspartate suggest that C0 2 and a
3-carbon acid may exchange at different rates on a C02 - fixing enzyme.
(2) The apparent cycling times of both glutamate and glutamine show fast components
measured in minutes and slow components measured in hours.
(3) With [l-14C]acetate in vitro glutamine is more rapidly labelled in C-1 than is
glutamate at early time points; the curves cross over at about 7 min.
(4) The results support and extend the concept of metabolic compartmentation of amino
acid metabolisn1 in brain.

of glutamate metabolism in brain, with various labelled precursors, both
in vivo (BERL, LAJTHA and W AELSCH, 1961; BERL, TAKAGAKI, CLARKE and W AELSCH,
1962; WAELSCH, BERL, ROSSI, CLARKE and PURPURA, 1964; BERLand CLARKE, in
press) and in vitro (BERL, NICKLAS and CLARKE, 1968), have repeatedly demonstrated
that in short term experiments the free glutamine usually has a higher specific activity
than the free glutamic acid. These observations were interpreted as evidence for
the compartmentation of glutamate metabolism in brain; the glutamate is distributed
in at least two metabolic pools, the smaller of which is particularly disposed toward
glutamine formation. O'NEAL and KOEPPE (1966) in their study of precursors in
vivo of glutamate, glutamine, and aspartate used 1~-labelled acetate, butyrate,
propionate, glucose, lactate, and glycerol. They confirmed the earlier studies on the
metabolism of administered r'C]glutamic acid and also confirmed the reports of
CREMER (1964) and GAITONDE (1965) that when labelled glucose is administered to
rats the specific activity of glutamate of brain is always greater than that of glutamine.
STUDIES

NASA Predoctoral Trainee grant No. Ns-G[T]-121 (1965-1968). Present address: Johnson
Research Foundation, Univ. of Pennsylvania, Philadelphia, Pa. Portions of this work were taken
from the thesis of W. J. N. which was submitted to Fordham University as partial fulfillment of the
requirements for the Ph.D. degree.
2 Supported by Public Health Service Research Career Program Award 5-KJ-NB-5117, National
Institute for Neurological Diseases and Blindness.
A preliminary report of this work was presented at the Federation Meetings in Chicago, Ill.,
April, 1967.
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In addition they reported that when precursors such as glucose, lactate, or glycerol
were used the specific activity of glutamine is always less than that of glutamic acid,
and conversely when glutamate, glutamine, or ketogenic precursors were used, such
as acetate, butyrate, or propionate the specific activity of glutamine was always
greater than that of glutamic acid. They suggested that the data could best be
explained by assuming two pools of tricarboxylic acid cycle intermediates, both
accessible to pyruvate but only one accessible to those metabolites which show compartmentation. Such a scheme would also account for the two pools of oxoglutarate
suggested by W AELSCH et a/. (1964) and GAITONDE (1965). More than one type of
tricarboxylic acid cycle was also suggested by VAN DEN BERG, MELA and W AELSCH
(1966), VAN DEN BERG, KRZALIC and MELA (1967) following their studies in mice
carried out with [1-14C]- and [2-14C]-acetate in comparison with [1-14C]-, [2-14C]- and
[6-14C]glucose. The latter authors suggested that glutamine derived from acetate is
coupled to the tricarboxylic acid cycle in a different manner than glutamine derived
from glucose. The subject was reviewed recently by BERL and CLARKE (in press).
Another experimental approach to the study of the pools of glutamate would
be to examine the distribution of label in the carbon skeletons of glutamic acid and
glutamine. It would be expected that a difference in the labelling patterns of glutamate
and glutamine would reflect the characteristics of the respective precursor pools of
oxoglutarate if they were not coupled to the citric acid cycle in the same fashion.
GAITONDE (1965) reported that C-1 of glutamine had a higher percentage of label
than did C-1 of glutamate in rat brain after the injection of [U-14C]glucose. However,
VAN DEN BERG (private communication) obtained results which seemed to be at
variance with those of GAITONDE.
In the series of experiments presented below, the percentage of radioactivity in
C-1 of glutamate and glutamine and C-4 of aspartate in brain were measured after
administration of [U-14C]glutamate, [U-14C]aspartate, or [1-14C]acetate in vitro
and [1-14C]acetate in vivo. In the in vivo experiments the labelling of the amino acids
in brain and liver were compared.
EXPERIMENTAL
Materials. L-[U-1 'C]Aspartic acid (> 200 p,c/p.mole), L-[U-14C]glutarnic acid (> 200 p,c/p,mole)
and [1-14C]sodium acetate (47·4 p,cfp,mole) were obtained from New England Nuclear Corp. The
resins used in the chromatographic separation of the amino acids were obtained from Bio-Rad Laboratories. The reaction flasks, septum stoppers and disposable center cups used in the enzymic
decarboxylations were purchased from Kontes Glass Co. Glutamate decarboxylase, Types I and III,
were obtained as acetone powders from Sigma Chemical Co. The scintillation fluors were obtained
from either Packard Instrument Co., New England Nuclear Corp., or Nuclear Associates, Inc.
2-Phenylethylamine was obtained from Eastman Organic Chemicals, and was vacuum distilled
before use. All other reagents were of analytical grade.
METHODS
Brain slices. Guinea pig cerebral cortex slices were prepared and incubated with labelled glutamate
or aspartate approximately 0·5 p,c/100 mg tissue as previously described (B.ERL eta/., 1968) or 5 p,c
of labelled acetate. After incubation with tracer, the slices were homogenized with 5 per cent TCA,
and the homogenate was centrifuged. Free glutamate, glutamine, and aspartic acid were separated on
AG-1 x 4 (acetate-form) columns and determined, and radioactivity was counted as described by
BERL et a/. (1968). The p-bis-(o-methylstyryl)-benzene (bis-MSB) yielded smaller variations in
quenching among various samples and so was substituted for dimethyl POPOP (BusH, 1966). When
slices were incubated with [l-14C]acetate, the glutamate and asparate fractions were evaporated to
dryness in vacuo at 50° and reconstituted with water prior to counting to remove any unmetabolized
[l-14C]acetate tracer eluted with these fractions. The glutamate fraction was more prone to contain
traces of labelled acetate than the asparate fraction.
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In vivo experiments. Approximately 15 p,c (0·3 ,umoles) of [1-14C]sodium acetate in isotonic
saline was injected intraperitoneally into male Swiss albino mice. After 5 min or 30 min an injected

mouse was stunned by a blow on the back of the neck and decapitated, and the brain and liver were
rapidly removed (within 1 min) and frozen in liquid N 2 • The frozen brain was weighed, homogenized
with 3 ml 5 per cent TCA, and transferred to a centrifuge cup. The residue in the homogenizing tube
was washed twice with 1 ml 5 per cent TCA, added to homogenate, and centrifuged for 15 min at
18,000 rev./min at 2°. The supernatant was adjusted to pH 7·0 ± 0·1 and a final volume of 7·5 mi.
3·0 ml positions were separated on resin columns (BERL et a/., 1968). The whole liver was treated
similarly except that 5·0 m1 5 per cent TCA were used for homogenization, and the tube was rinsed
twice with 2 ml portions of 5 per cent TCA. The final volume, after neutralization, was 14·0 mi.
Decarboxylation of C-1 ofglutamic acid and glutamine. C-l of glutamic acid was decarboxylated
by a modification of the method of GALE (1954). Two ml of a 0·05 per cent suspension (in 0·1 Nacetate buffer, pH 5·1) of an acetone powder from E. coli with glutamate decarboxylase Type I activity
were pipetted into a 10 m1 reaction flask. A disposable plastic center cup was inserted into a rubber
septum stopper, and this assembly inserted into the flask. 2-Phenylethylamine (0·2 ml) (WOELLER,
1961) was injected into the center cup through the septum. One ml of the labelled glutamic acid solution was mixed with the enzyme suspension by injection. It was found that at least 500 counts/min
should be injected to achieve acceptable precision of results ( ± 1 per cent). The same syringe was
used to measure 1 ml of labelled glutamate for counting the total radioactivity. The flask was incubated in a reciprocal shaker for 2 hr at 37°. At the end of this time period, the center cup was severed
from its stem with a hone-cutter directly into a counting vial containing 0·5 ml water and 10 ml of
counting solution. Each sample was determined in duplicate. The radioactivity remaining in the
residue after decarboxylation was also measured. Numerous control determinations with [U14C]glutamate and [l- 14C]glutamate indicated that the decarboxylation proceeded to 95-98 per cent
completion. The percentage of label in C-1 of glutamine was measured after initial hydrolysis to
glutamate with 2 N-HO for 2 hr at 100°. There-isolated glutamate was then decarboxylated.
Decarboxylation ofC-4 of aspartate. Aspartate was decarboxylated with an acetone powder of
Cl. welchii (glutamate decarboxylase Type III) which contains aspartate-P-decarboxylase activity.
MEISTER, SoBER and TICB (1951) showed that ex-alanine and C02 are the reaction products from
aspartate with this preparation. Twenty mg of the acetone powder suspended in 2 mi 0·1 M·Na-acetate
buffer, pH 5·1, were placed in the reaction flask, and the procedure as described above for
decarboxylation of glutamate was used. Again, numerous control experiments showed that the decarboxylation proceeded to 94-98 per cent completion.
RESULTS

Brain slices incubated with [U- 14C]glutamate or aspartate. The distribution of
radioactivity in the amino acids and their specific activities were described (BERL
et a/., 1968). In the present study many of these samples, as well as others, were
further examined for distribution of label within the carbon skeleton of the molecules {Table 1). The labelled amino acids as obtained from the supplier and used as
TABLE !.-DECARBOXYLATION OF GLUTAMATE, GLUTAMINE, AND ASPARTATE ISOLATED FROM GUINEA
PIG BRAIN SUCES INCUBATED WITH L-[U-UC]GLUTAMATB OR L-(U-14C]ASPARTATB
Isolated amino acid
Tracer added
Glutamic acid Aspartic acid Glutamic acid
Glutamine
Aspartic acid
C-1
C-4
C-1
C-1
C-4
L-[U-14C]Glutamate
L-[U-14C]Aspartate

± 0·4
(N = 12)

19·5

25·6 ± 0·3
(N = 10)

21·8 ± 0·34*
(N = 12)
37·2 ± 1·3*
(N = 14)

22·6 ± 0·65*
(N = 14)
39·9 ± 1·6*
(N = 12)

26·75
(N

± 0·34*
= 10)

24·4 ± 0·4
(N = 11)

The results are given as % label ± S.D. N = number of samples.
The tissue and slices were kept at room temperature until incubated at 37°. The medium used
was Krebs-Ringer phosphate containing 1 per cent glucose. Approximately 100 mg of slices and 2·5
ml of medium containing 0·5 p,c of radioactive tracer ( > 200 flC/p,mole) were used. The slices were
preincubated at 37° for 10 min and transferred to fresh medium before addition of isotope and
incubated for 10-30 min.
. * Significantly different from anticipated results (P < 0·01).
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precursors contained, within experimental error, the expected distribution of label
in C-1 of glutamate (20·0 per cent) and in C-4 of aspartate (25·0 per cent). Following
incubation of guinea pig brain cortex slices with L- [U-14C]glutamate the C-1 of the
isolated glutamate and glutamine showed a similar small but significant increase
in percentage of radioactivity (P < 0·01). The C-4 of the isolated aspartic acid
also was greater than the expected value of25·0 per cent (P < 0·01). When L-[U-14C]aspartate was the labelled precursor the C-1 of both glutamate and glutamine contained a higher percentage of radioactivity than the anticipated maximum of 33·3 per
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FIG. I.-Decarboxylation of glutamate, glutamine and aspartate from guinea pig
brain cortex slices incubated with sodium [1-14 C]acetate. See Table 1 for methods of
tissue preparation and incubation except that 5 p,c sodium [1-14 C]acetate (58 p,c/
p,mole) were used.

cent. The percentage of label in C-4 of the isolated aspartic acid appeared to be
lower than that of the starting material but not significantly lower than the theoretical
value of 25·0 per cent. Slices incubated for 10, 20, and 30 min did not show significant differences from each other in percentage distribution of label in the carbon
skeleton and therefore the data were averaged for inclusion in Table 1.
Brain slices incubated with [1-UC]sodium acetate. At the early time points, up
to 5 min, the percentage of label in C-1 of glutamine was significantly greater than
in the corresponding carbon atom of glutamate (Fig. 1). Mter an initial rise the
glutamine curve declined and then showed a secon~ but slow increase. The glutamate
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curve rose continuously, and the curves crossed at approximately 7 min. The per centage of label in C-4 of aspartate was approximately 64 per cent at the earliest experimental time point (5 min) and decreased to approximately 55 per cent at 30 min
(samples obtained at shorter time periods contained too little radioactivity for
precise measurement).
In vivo administration of [1- 14C]sodium acetate. When [1-14C]acetate was administered as a single dose intraperitoneally the percentage of radioactivity in C-4 of
TABLE 2 . -DISTRIBUTION OF LABEL IN GLUTAMATE AND ASPARTATE IN BRAIN AND LIVER OF MICE AFTER
ADMINISTRATION OF [l-14 C]ACETATE

% label in C-4

% label in C-1
Time
(min)
5

Brain
Glutamate
Glutamine
14·3

± 0·5

(N = 4)

30

46·1 ± 3·8
(N = 4)

11·5

± 0·5

(N = 3)

32·9 ± 3·3
(N = 4)

Liver
Glutamine
Glutamate

Brain
aspartate

16·0 ± 1·7
(N = 4)
40·2 ± 5·0
(N = 4)

63·6 ± 0·7
(N = 4)
60·7 ± 0·5
(N = 4)

20·5

± 2·5

(N = 4)

47·9

± 4·7

(N = 4)

Liver
aspartate
46·2

± 3·9

(N = 4)

49·3

± 1·9

(N = 4)

The results are given as % label ± s.n. N = number of samples.
15 !J.C sodium [l-14C]acetate in 0·1 ml saline was injected intraperitoneally into each mouse.
After 5 or 30 min the mouse was decapitated, and the brain and liver were excised within 1 min and
immediately frozen in liquid nitrogen.

aspartate behaved similarly to that observed in vitro. It decreased from a value
of approximately 64 per cent at 5 min to a value of approximately 61 per cent at 30
min (Table 2). On the other hand, in liver the C-4 of aspartate showed no significant
difference from the theoretically predicted value of 50 per cent at both 5 and 30 min.
The percentage of label in C-1 of both glutamate and glutamine from each tissue
showed similar trends; it increased 2-3 fold between 5 and 30 min. In liver the
percentage of label in C-1 of glutamine was lower than that in C-1 of glutamate but
the differences were significant only at the 10 per cent probability level (Table 2).
DISCUSSION

When [1-14C]acetate is used in vivo for the labelling of the amino acids of brain
it is important to demonstrate that the label is not being carried to the brain after
prior conversion to glucose in the liver. A precedent for this concern is the demonstration by KoEPPE and HAHN (1962) that [2-14C]alanine does label glutamic acid of
brain after prior conversion to [1 ,2,5,6-14C]glucose. Glucose formed in the liver
from [1-14C]acetate would be labelled in the 3 and 4 positions. This radioactivity
would be lost on conversion to acetyl-CoA in the brain. However, [1-14C]pyruvate
formed from this glucose could label amino acids by entering the citric acid cycle
via C02 fixation. This would produce glutamate labelled exclusively at C-1. The
data in Table 2 show that in 5 min less than 15 per cent of the label is in this carbon
atom. Studies in the cat by BERL and FRIGYESI (unpublished observation) show
similar results and there is correspondingly less label in C-1 at shorter time periods.
In slice experiments (Fig. 1), where the problem of liver metabolism is not present,
the percentage of label in C-1 of glutamate and glutamine were also low at early
time points.
A large body of evidence indicates that in brain, glutamate and glutamine are
distributed in more than one metabolic pool or compartment. A comparison of
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the percentage of radioactivity in C-1 of glutamine and glutamate obtained from
slices incubated with [l-14C]acetate lends further support to this concept. At early
time points (Fig. 1) C-1 of glutamine had a greater percentage of label than did C-1
of glutamate. Hence the total content of glutamic acid in the cerebral cortex could
not be the precursor of the tissue glutamine.
[1-14C]acetate first labels C-5 of glutamate exclusively (Fig. 2). It is only in the
second turn through the citric acid cycle that C-1 of glutamate becomes labelled.
Therefore, the accumulation of radioactivity in C-1 of glutamate is a measure of the
A c etate

F1o. 2.-The label entering the cycle is indicated by the solid squares. At the level of

succinate where the label distributes itself between equivalent positions triangles are
used to follow the label. Those positions indicated by triangles have one-half the label
in the positions indicated by squares.

apparent turnover time of glutamate through the citric acid cycle. As FREEDMAN and
GRAFF (1958) pointed out, if there is a continuous feed of [1-14C]acetate, the percentage of label in C-1 should achieve a maximum of 33·3 per cent during the second
turn of the cycle and not change thereafter; the remainder of the radioactivity
(66·7 per cent) is in C-5. In a single pulse label experiment with [l-14C]acetate half
the radioactivity in glutamate is lost as C02 in each complete turn of the cycle. Since
no further radioactivity is fed into C-5 all the activity in glutamate can theoretically
end up in C-1.
The in vitro studies (Fig. 1) approximated a continuous dosage experiment while
the in vivo studies were more nearly a single pulse label experiment. This was evident
from the observation that in the former experiments a large percentage of the radioactivity was present in the tissue as unmetabolized acetate whereas in the latter
no volatile radioactivity could be detected in the TCA extract. Thus in the in vitro
experiments the radioactivity in C-1 of glutamate and glutamine remained well
below the theoretical maximal value (33·3 per cent). Hence the large pool of
glutamate had not completely recycled within 30 min.
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An attempt was made to estimate the cycling times of glutamate and glutamine
pools by using appropriate data from Fig. 1 which were replotted on a semi-log
scale as the change in radioactivity in C-5 (100- percentage in C-1) with time
(Fig. 3). The glutamate showed a diphasic curve. The fast component had an
apparent cycling time of 6 min and the slow component one of 5·5 hr. The glutamine
curve was more complex and therefore the estimation of apparent cycling time was
much less reliable. It is evident that the most rapid glutamine component is faster
than that of glutamate and is less than 4 min. The slower components are more
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FIG. 3.-Data from Fig. 1 replotted on a semi-log scale. %label in C-5 = (100in C-1).

%

difficult to disassociate from each other. However, it would appear that radioactivity
which entered glutamine cycled very slowly, an observation previously made by
VAN DEN BERG et al. (1966). BERL and FRIGYESI (1969) found in brain tissue of
cats injected i.v. with [1-14C]acetate that the specific activities of both glutamate
and glutamine show diphasic decay curves. The fast component of each has a
half-life measured in minutes whiles the slow component of each is measured in
hours. In addition glutamine turns over more slowly than does glutamate.
In the in vivo experiments the radioactivity in C-1 of glutamate of brain and liver
approached 50 per cent at the 30 min time point (Table 2). The percentage of label
in C-1 of glutamine was less than that in C-1 of glutamate even at the shortest time
point of 5 min. This is different from results obtained in the slice experiments.
However, it is quite possible that this is not a fundamental difference and that a
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crossover of the glutamate and glutamine curves might have occurred at an earlier
time point than 5 min in the in vivo experiments.
The percentages of radioactivity in C-1 of glutamine and glutamate were not
significantly different from each other when brain cortex slices were incubated with
either L- [U-14C]glutamate or L- [U-14C]aspartate as the tracer metabolite (Table 1).
However, based on the results obtained with labelled acetate, smaller differences
Glcose
P ruvate

~OOH

~~~H

~OOH

~tooH

bToOH

~ ~~~ ;::t:i-£~~H2

Fro. 4.-For the experiments with unifonnly labelled aspartate

~

= {3 =

y

=

~.

would be expected between C-1 of glutamate and glutamine with these tracers.
These differences would be of the same order as the standard deviation of the experiments and therefore could very well have been obscured.
The finding that the percentage of activity in C-1 of glutamate and glutamine
was significantly higher than that of the initial glutamate indicates that the added
substrate cycled significantly with resultant dilution of C-4 and C-5 and relative
enrichment of C-1. Furthermore, from a theoretical consideration of the flow of
individual carbon atoms through the citric acid cycle from uniformly labelled aspartate (or glutamate), in the presence of unlabelled glucose, all of the radioactivity
in glutamate and glutamine should reside equally in carbons 1, 2 and 3 (Fig. 4).
Thus, unless one of the four-carbon dicarboxylic acids of the citric acid cycle is
handled asymmetrically this relationship should not change with time, and the
percentage of label in C-1 should never exceed 33·3 per cent. When [U-14C]aspartate
was the tracer the percentage of radioactivity in C-1 of glutamate and glutamine was
significantly greater than 33·3 per cent (Table 1). Care was taken to demonstrate
that the added uniformly labelled aspartate did in fact contain 25 per cent of the
label in C-4. In addition, the aspartate isolated from the tissue still contained 25 per
cent of the label in C-4 within experimental error.
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One possible explanation of the results would be that the carboxyl groups of
succinate and fumarate are distinguished from each other in the citric acid cycle.
However, there is no evidence in the literature for such a postulate. This hypothesis
would suggest that if [1-14C]acetate is the labelled substrate, C-1 of aspartate should be
more heavily labelled than C-4 (Fig. 2). However, in experiments with [l-14C]acetate,
both in vivo and in vitro, C-4 of aspartate contained a significantly greater percentage
of the label than did C-1 (Table 2; Fig. 1). This additional labelling of C-4 of
aspartate by [1-14C]acetate, as well as the excess labelling of C-1 of glutamate by
[U-14C]aspartate, is consistent with a selective dilution of C-1, 2, and 3 of oxaloacetate
as compared to C-4 of this metabolite. The most likely mechanism which can be
suggested for this process is an independent exchange of pyruvate and C02 in oxaloacetate. The pyruvate carboxylase reaction is known to be important in the synthesis
of oxaloacetate in brain (FELICIOLI, GABRIELLI and Rossi, 1967) although other C02
fixing systems rnay also be operative. If, on the enzyme, pyruvate exchanges more
readily than does C02 both of the above experimental paradoxes can be explained.
UTIER and KEEcH (1963) showed that the apparent Km for pyruvate is lower than
that for C02 with pyruvate carboxylase from avian liver. Although data for the
liver {Table 2) do not show uneven labelling of the aspartate this may be due to a
more rapid 'dicarboxylic acid shuttle' in liver than in brain (BERL eta/., 1962).
Such a suggestion of independent rates of exchange of pyruvate and C02 was
proposed by HASLAM and KREBs (1963) for brain in vitro. However, they obtained
a lower percentage of radioactivity in C-4 of aspartate than in the remainder of the
molecule from [5-14C]glutamate.
There were several differences between the experimental procedures used by the
two laboratories: (1) brain slices were incubated in glucose-free medium by HASLAM
and KREBs and in medium containing I% glucose by us; (2) substrate levels of
labelled glutamate were added to the incubation medium by the former authors
whereas we added only tracer quantities of labelled acetate and no glutamate; (3)
their medium did not contain Ca2+ and ours did. Therefore we have a large source
of unlabelled pyruvate to exchange with the labelled pyruvate on a carbon dioxide
fixing enzyme while they do not. Hence the same exchange process could lead to the
opposite results obtained by the two laboratories. No difference in labelling between
C-1 and C-4 of aspartate was found by SIMON, CoHEN and BERRY, (1968) who studied
the distribution of label in aspartate after the incubation of brain slices with [5-14C]glutamate. These authors used much longer incubation periods (1·5 hr) than those of
the experiments reported here and by HASLAM and KREBs. It is evident from Fig. 1
that the difference in labelling between C-1 and C-4 of aspartate decreases with
time so that in the experiments of longer duration these differences may disappear.
The absence of Ca2+ from the incubation medium has a profound effect on the
compartmentation of the glutamate-glutamine system in brain slices (BERL, CLARKE
and NICKLAS, in preparation). Whether or not it also affects the distribution of
label in aspartate is not known.
The studies described above give independent evidence for the metabolic compartmentation of the glutamate-glutamine system and support the previous evidence
for this postulate.
The specific activity of the glutamine was always greater than that of the glutamic
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acid in all the experiments with [L14C]acetate. These data will be presented in a
separate communication {BERL, NICKLAS and CLARKE, in preparation).
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